Journals / Türk Kardiyoloji Derneği Arşivi / 2002 / Cilt: 30 - Sayı: 9

Comparative study of diltiazem, nitroglycerin and sodium nitroprusside for controlling hypertension following coronary artery bypass surgery

Koroner baypas cerrahisi sonrası hipertansiyon kontrolünde diltiazem, nitrogliserin ve sodyum nitroprussidin karşılaştırılması

Pages
530–533
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mean arterial pressure decreased significantly within all groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypertension following coronary artery bypass grafting is a common problem.
📊
Key Findings & Data:For this reason 45 patients were equally allocated into 3 groups.
💡
Conclusion & Impact:Mean arterial pressure decreased significantly within all groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hypertension following coronary artery bypass grafting is a common problem. Various drugs are used for the control of hypertension during this period which is known to be vulnerable for postoperative myocardial infarction and bleeding. The aim of this study was to compare the hemodynamic effects of diltiazem, nitroglycerin, and sodium nitroprusside. For this reason 45 patients were equally allocated into 3 groups. In group 1, diltiazem was administered as a 0.3mg/kg IV-bolus within 5 minutes followed by an infusion of 0.1-0.8mg/kg/hr; in group 2, nitroglycerin as a 1-3µg/kg/min infusion, and in group 3 sodium nitroprusside as a 1-3µg/kg/min infusion. Hemodynamic measurements were done before treatment (T1), and 30 min (T2), 2 hours (T3) and 12 hours (T4) thereafter. Mean arterial pressure decreased significantly within all groups (p

Özet

Hipertansiyon aorto-koroner baypas greftleme operasyonu sonrası yoğun bakımda sıkça karşılaşılan bir sorundur. Postoperatif miyokard infarktüsü ve kanama açısından son derece tehlikeli olan bu dönemin sorunsuz geçilebilmesi için günümüzde değişik farmakolojik ajanlar kullanılmaktadır. Biz bu çalışmamızda diltiazem, nitrogliserin ve sodyum nitroprussid gibi üç farklı antihipertansif ajan kullanımının hemodinami üzerine olan etkisini araştırmayı amaçladık. Bu amaçla 45 hasta randomize olarak 3 eşit gruba ayrıldı. Grup 1: 0.3mg/kg diltiazemin 5 dakikada bolus verilmesini takiben, 0.1-0.8mg/kg/saat doz aralığında infüzyon yapılan hastalardan, grup 2: 1-3µg/kg/dakika hızında nitrogliserin infüzyonu, grup 3: 1-3µg/kg/dakika hızında sodyum nitroprussid infüzyonu alan hastalardan oluşmakta idi. Tüm olguların postoperatif yoğun bakımda, antihipertansif ajan başlamadan önce bazal (T1), başladıktan 30 dakika (T2), 120 dakika (T3) ve 12 saat (T4) sonra hemodinamik ölçümleri yapıldı. Grupların kendi içlerinde ortalama arter basıncı (OAB) değişimi incelendiğinde, tüm gruplarda bazal değerlerle diğer tüm zaman dilimlerindeki giderek azalan OAB değerleri arasındaki farkın anlamlı olduğu görüldü (p

🔖

Cite This Article

TORAMAN, F., ÖZYURT, A., YURTSEVEN, N., CANİK, S., EVRENKAYA, S., GÖKSEL, O., ÖZTİRYAKİ, H., AKSOY, N., ÇALIŞIRİŞÇİ, Ü., DAĞDELEN, S., KARABULUT, H., ALHAN, C. (2022). Comparative study of diltiazem, nitroglycerin and sodium nitroprusside for controlling hypertension following coronary artery bypass surgery. Türk Kardiyoloji Derneği Arşivi, Cilt: 30 - Sayı: 9, 530–533. https://ajindex.com/articles/633976

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ferguson BT, Hammill BG, Peterson ED, DeLong ER, Grover FL for the STS National Database Committee: A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and Duke Clinical Research Institute. Ann Thorac Surg 2002
  2. 9 2. Higgins TL: Safety issues regarding early extubation after coronary artery bypass surgery. J Cardiothoracic Vasc Anesth 1995
  3. 9 3. Hoshide S, Kario K, Mitsuhashi T et al: Different patterns of silent cerebral infarct in patients with coronary artery disease or hypertension. Am J Hypertens 2001
  4. 15 4. Joyal M, Cremer KF, Pieper JA, Feldman RL, Pepine CJ: Systemic, left ventricular and coronary hemodynamic of intravenous diltiazem in coronary artery disease. Am J Cardiol 1985
  5. 7 5. Kenny J, Daly K, Bergman G, Kerkez S, Jewitt DE: Beneficial effects of diltiazem in coronary artery disease. Br Heart J 1984
  6. 6 6. Pepine CJ, Joyal M, Cremer KF, Hill JA, Feldman RL, Gelman JS: Hemodynamic effects of nitroglycerin combined with diltiazem in patients with coronary artery disease. Am J Med 1984
  7. 51 7. Joyal M, Pieper J, Cremer K, Feldman RL, Pepine CJ: Pharmacodynamic aspects of intravenous diltiazem administration. Am Heart J 1986
  8. 61 8. Opie LH, Schall R: Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy. J Am Coll Cardiol 2002
  9. 22 9. Morgan TO, Anderson AI, MacInnis RJ: ACE inhibitors, beta-blockers, calcium blokers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001
  10. 7 10. Diamond JA, Krakoff LR, Goldman A et al: Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension. Am J Hypertens 2001
  11. 40 11. Opie LH: Calcium channel blokers in hypertension: reappraisal after new trials and major meta-analyses. Am J Hypertens 2001
  12. 81 12. Işık A, Lüleci C, Çeliker H, Arslan N, Dönder E, Alaşehirli E: Esansiyel Hipertansiyonlular ve sağlıklı bireylerde I. kuşak antagonistlerinin sol ventrikül diyastolik fonksiyonlarına akut etkileri. Türk Kardiyol Dern Arş 1992
  13. 52 13. Breisblatt WM, Navratil DL, Burns MJ, Spaccavento LJ: Comparable effects of intravenous nitroglycerin and intravenous nitroprusside in acute ischemia. Am Heart J 1988
  14. 72 14. Simon AC, Levenson JA, Levy BY, Bouthier JE